Investor Center

• Press Releases
• Events & Presentations
• Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Contact the Board
  • Insider Transactions
  • Director & Officer Ownership
• Financial Information
  • SEC Filings
  • Annual Reports
  • Quarterly Results
  • Key Ratios
• Stock Information
  • Historic Stock Lookup
  • Investment Calculator
  • Analyst Coverage
  • Ownership Profile
• Investor FAQs
• Contact Us

     

Committee Composition

= Chair = Member

	Audit	Compensation	Nominating and Governance
Bucci, Vincent
Chairman of the Board Vincent Bucci joined the Company's Board of Directors in January 2007 and was named Chairman in July 2007. From 1999 to 2007, Mr. Bucci served as Chairman of the Board of Directors of RITA Medical Systems Inc., which AngioDynamics acquired in January 2007. Mr. Bucci has been President of Health Policy Associates Inc., a consulting company, since 1992. Mr. Bucci has a B.A. from Bates College, as well as a J.D. in public law and an M.A. in government, both from Georgetown University.
Donnelly, Howard
Director Howard W. Donnelly joined the AngioDynamics' Board of Directors in March 2004. Mr. Donnelly is President of Concert Medical LLC, a contract manufacturer of interventional medical devices. In addition, Mr. Donnelly is a Principal in a privately held start-up medical device company targeting the regional anesthetic market. From 1999 to 2002, he was President of Level 1 Inc., a medical device manufacturer and a subsidiary of Smiths Group. From 1990-99, Mr. Donnelly was employed at Pfizer Inc., with his last position being Vice President, Business Planning and Development, for Pfizer's Medical Technology Group from 1997-99.
Echenberg, Paul
Director Paul S. Echenberg has been a Director since 1996 and served as Chairman of the AngioDynamics Board of Directors from February 2004 to July 2007. Mr. Echenberg has been the President, Chief Executive Officer and a Director of Schroders & Associates Canada Inc., an investment buy-out advisory services company, and a Director of Schroders Ventures Ltd., an investment firm, since 1996. He also is a founder, and has been a General Partner and Director, of Eckvest Equity Inc., a personal investment and consulting services company, since 1989. From 1970-89, Mr. Echenberg was President and Chief Executive Officer of Twinpak Inc. and Executive Vice President of CB Pak Inc., both packaging companies. He also co-founded BDE & Partners, an investment banking and strategic advisory services firm, in 1991, and is a Director of Lallemand Inc. and Benvest New Look Income Trust.
Gold, Jeffrey
Director Jeffrey G. Gold has served as Director since 1997. Mr. Gold is a Venture Partner for Longitude Capital, a healthcare venture capital fund. Mr. Gold was President and Chief Executive Officer of CryoVascular Systems, a peripheral vascular disease device company, from 2001 through its sale to Boston Scientific in 2005. From 1997 to 2001 he was Executive Vice President and Chief Operating Officer of CardioThoracic Systems Inc., a company engaged in the development and introduction of devices for beating-heart coronary bypass surgery. Before that, Mr. Gold spent 18 years with Cordis Corporation in a variety of senior management roles, including Vice President of Manufacturing and Vice President of Research and Development, and was a co-founder and President of Cordis Endovascular Systems, a Cordis subsidiary engaged in the interventional neuroradiology business. At Cordis, Mr. Gold also had responsibility for the peripheral vascular business. He serves on the board of directors of several start-up medical device companies and is a member of the Executive Committee for the Center for Entrepreneurship and Innovation at the University of Florida, as well as the Commercialization Advisory Board for the Cleveland Clinic.
Johnson, Wesley
Director Wesley E. Johnson Jr. joined the Company's Board of Director's in January 2007. From 2003-07, Mr. Johnson served as a member of the board of RITA Medical Systems Inc. Since February 2008, Mr. Johnson has served as President, Chief Executive Officer and director of Cardiokinetix Inc., a developer of medical devices for the treatment of congestive heart failure. From October 2005 to February 2008 he served as General Manager of Abbott Spine S.A., a division of Abbott Laboratories. From June 2003 to October 2005, Mr. Johnson served as Division Vice President, Finance for Abbott Spine. From May 1999 to June 2003 he served as Vice President of Operations and Chief Financial Officer for Spinal Concepts. Mr. Johnson has a B.B.A. in accounting from Texas A&M University and became a Certified Public Accountant in 1981.
Keltjens, Jan
President and CEO, Director Jan Keltjens became AngioDynamics' President and Chief Executive Officer on March 1, 2009. Born and raised in the Netherlands, Mr. Keltjens has a master's degree in physics from the University of Eindhoven and more than 20 years of medical industry leadership experience. Mr. Keltjens previously served as President and Chief Executive Officer of CryoCath Technologies Inc., a leader in cryotherapy products for treating cardiac arrhythmias from March 2007 until its acquisition by Medtronic Inc. in February 2009. Mr. Keltjens is also currently a Director of a privately held European company. From 2000-07, he served as Worldwide General Manager of Cordis Neurovascular, a Johnson & Johnson company. He joined Cordis in 1995 as Vice President and Managing Director responsible for international manufacturing and distribution operations, as well as research and development. He was promoted to Vice President of European Marketing for all Cordis divisions in 1998 and Vice President of Worldwide Strategic Marketing for Cordis Cardiology, based in Miami, in 1999. Before joining Cordis, Mr. Keltjens led research and development departments at Unilever and was Managing Director of a group of small high tech companies.
Meteny, Dennis
Director Dennis S. Meteny joined the AngioDynamics Board of Directors in March 2004. Mr. Meteny is President and Chief Executive Officer of Cygnus Manufacturing Company LLC, a privately held manufacturer of minimally- and non-invasive medical device products; health and safety components; and high-precision transportation, aerospace and industrial products. From 2003-06, Mr. Meteny was an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse, a strategic economic development initiative of the University of Pittsburgh Health System, Carnegie Mellon University, the University of Pittsburgh, the state of Pennsylvania and local foundations. From 2001-03 he was President and Chief Operating Officer of TissueInformatics Inc., a privately-held company engaged in the medical imaging business. From 2000-01, Mr. Meteny was a business consultant to various technology companies. Prior to that, Mr. Meteny spent 15 years in several executive-level positions, including as President and Chief Executive Officer from 1994-99, of Respironics Inc., a cardio-pulmonary medical device company. Mr. Meteny holds a B.S. in accounting from The Pennsylvania State University and an M.B.A. from the University of Pittsburgh.
LaPorte, Steve
Director Steve LaPorte joined the AngioDynamics Board of Directors in January 2007. From 2005-07, Mr. LaPorte served as a member of the RITA Medical Systems Inc. Board of Directors. Mr. LaPorte is a Venture Partner for Onset Ventures, serves as the Chief Technology Officer for Intelect Medical, and serves on the boards of Valeritas and Biocontrol. From 2002 until his retirement in August 2005, Mr. LaPorte served as Vice President of Neuro Ventures and Business Development at Medtronic Inc., a global leader in medical technology. From 2000-02, Mr. LaPorte served as Vice President and General Manager of Medtronic's Drug Delivery Division; from 1994 to 2000, he held the position of Vice President and General Manager of Medtronic's Electrophysiology Systems Division; and from 1988-94 he was the Vice President of Operations for Medtronic's Neurological Division. He began his career at Medtronic in 1978. Mr. LaPorte received his M.B.A. from the University of Minnesota and a B.S. in mathematics and computer science from the University of Wisconsin-Stevens Point.
Orsatti, Charles
Director Charles Orsatti joined the Company's Board of Directors in October 2008. Mr. Orsatti has been a Director of SRI Surgical Inc., a central processing and supply chain management services company serving hospitals and surgery centers, since 2004; Biotronic NeuroNetwork Inc., an interoperative neuro monitoring company serving hospitals and major surgery centers, since 2009; Ossur Americas Ltd., an orthopedic and prosthetic manufacturer, since 2008; and Gyntec Inc., a late stage development company for women's healthcare products, since 2007. Mr. Orsatti also served as a Board Chairman and Director of djOrthopedics Inc., a NYSE-listed orthopedic sports medicine company, from 1998 until 2007. Since 1995, Mr. Orsatti has been Chairman and Managing Partner of Fairfield Capital Partners Inc., a private equity investment firm. Prior to 1995, Mr. Orsatti was Chairman and Chief Executive Officer of Fairfield Medical Products Corporation, a manufacturer of critical care products. From 1983-86 he was Chief Executive Officer of Coloplast Inc., a manufacturer of single use products, and then served as Chief Operating Officer and President of two medical divisions of British Oxygen Corporation. Mr. Orsatti began his career with the medical products division of Air Products and Chemicals Inc. and subsequently worked for the Critikon Division of Johnson & Johnson.